As of 2025-08-10, the Relative Valuation of Charles River Laboratories International Inc (CRL) is 40.09 USD. This relative valuation is based on P/E multiples. With the latest stock price at 148.74 USD, the upside of Charles River Laboratories International Inc based on Relative Valuation is -73.0%.
The range of the Relative Valuation is (14.53) - 120.06 USD.
| Range | Selected | |
| Trailing P/E multiples | 22.6x - 29.8x | 27.0x |
| Forward P/E multiples | 23.2x - 32.9x | 26.8x |
| Fair Price | (14.53) - 120.06 | 40.09 |
| Upside | -109.8% - -19.3% | -73.0% |
| Date | P/E |
| 2025-08-08 | -231.48 |
| 2025-08-07 | -233.10 |
| 2025-08-06 | -233.95 |
| 2025-08-05 | -260.66 |
| 2025-08-04 | -261.33 |
| 2025-08-01 | -259.75 |
| 2025-07-31 | -264.00 |
| 2025-07-30 | -274.20 |
| 2025-07-29 | -277.71 |
| 2025-07-28 | -278.55 |
| 2025-07-25 | -275.35 |
| 2025-07-24 | -275.61 |
| 2025-07-23 | -261.37 |
| 2025-07-22 | -254.23 |
| 2025-07-21 | -233.11 |
| 2025-07-18 | -240.41 |
| 2025-07-17 | -243.86 |
| 2025-07-16 | -241.13 |
| 2025-07-15 | -240.32 |
| 2025-07-14 | -245.95 |
| 2025-07-11 | -248.07 |
| 2025-07-10 | -254.70 |
| 2025-07-09 | -247.40 |
| 2025-07-08 | -246.49 |
| 2025-07-07 | -239.51 |
| 2025-07-03 | -244.52 |
| 2025-07-02 | -245.09 |
| 2025-07-01 | -240.29 |
| 2025-06-30 | -236.13 |
| 2025-06-27 | -233.45 |
| 2025-06-26 | -235.91 |
| 2025-06-25 | -233.76 |
| 2025-06-24 | -230.95 |
| 2025-06-23 | -229.36 |
| 2025-06-20 | -229.47 |
| 2025-06-18 | -226.11 |
| 2025-06-17 | -225.73 |
| 2025-06-16 | -235.04 |
| 2025-06-13 | -232.58 |
| 2025-06-12 | -236.38 |
| 2025-06-11 | -235.17 |
| 2025-06-10 | -234.99 |
| 2025-06-09 | -229.49 |
| 2025-06-06 | -225.19 |
| 2025-06-05 | -219.74 |
| 2025-06-04 | -222.89 |
| 2025-06-03 | -215.53 |
| 2025-06-02 | -210.16 |
| 2025-05-30 | -211.07 |
| 2025-05-29 | -214.30 |